Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Return on Capital Employed (2016 - 2025)

Avanos Medical (AVNS) has disclosed Return on Capital Employed for 12 consecutive years, with 0.07% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 25.0% to 0.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07% through Dec 2025, up 25.0% year-over-year, with the annual reading at 0.06% for FY2025, 25.0% up from the prior year.
  • Return on Capital Employed hit 0.07% in Q4 2025 for Avanos Medical, up from 0.53% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.03% in Q4 2022 to a low of 0.53% in Q3 2025.
  • Historically, Return on Capital Employed has averaged 0.09% across 5 years, with a median of 0.01% in 2022.
  • Biggest YoY gain for Return on Capital Employed was 25bps in 2025; the steepest drop was -56bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.03% in 2021, then soared by 214bps to 0.03% in 2022, then tumbled by -91bps to 0.0% in 2023, then tumbled by -11320bps to 0.32% in 2024, then soared by 79bps to 0.07% in 2025.
  • Business Quant data shows Return on Capital Employed for AVNS at 0.07% in Q4 2025, 0.53% in Q3 2025, and 0.5% in Q2 2025.